What the US FDA sees as new and emerging methods of manipulation to defeat abuse-deterrent formulations, Pain Therapeutics sees as moving the goalposts for regulatory approval.
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
